Cartesian Therapeutics's total assets for Q1 2025 were $409.13M, a decrease of -5.95% from the previous quarter. RNAC total liabilities were $430.92M for the fiscal quarter, a -2.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.